Open original FDA record ↗Recall record
- FDA identifier
- Z-1282-2012
- Company in FDA record
- Becton Dickinson & Co.
- FDA classification date
- Mar 23, 2012
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 17, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
In vitro diagnostic reagent is defective and may fail to enhance the growth of microbiological cultures as intended.
Source facts
- Action
- Becton Dickinson (BD) sent an "URGENT PRODUCT RECALL" letter dated February 2012 to all affected customers. The letter identifies the product, problem, and actions to be taken by the customers. The letter instructs customers to discontinue use and discard any remaining affected product. BD will issue replacements for the discarded product. Additionally, an Acknowledgment Form was attached for customers to complete and return to the firm via fax to 410-316-4258. Contact BD Technical Services Department for questions regarding this notice.
- Initiated
- 2012-02-20
- Root cause
- Nonconforming Material/Component
- Terminated
- 2012-06-18
- Distribution
- Worldwide Distribution-USA (nationwide) and the countries of Belgium, Canada, China, Japan, Mexico, and Taiwan.
- Recall number
- Z-1282-2012
- Recall status
- Terminated
- CDRH record ID
- 107775
- FDA classified
- 2012-03-23
- Recall event number
- 61305